Replacement. Replaces: NICE Implementation Policy C/YEL/gen/09.
|
|
- Charles Newton
- 5 years ago
- Views:
Transcription
1 Clinical NICE Implementation Policy Document Control Summary Status: Replacement. Replaces: NICE Implementation Policy C/YEL/gen/09. Version: v1.0 Date: November 2015 Author/Title: Owner/Title: Steven Hazeldine- Clinical Audit Team Leader Liz Lockett - Associate Director of Quality & Risk Approved by: Policy and Procedures Committee Date: 17/12/2015 Ratified: Trust Board Date: 28/01/2016 Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words: Provide high quality recovery focused services January 2016 January 2019 NICE. Guidelines. Guidelines. Effective. Standards. Best practice. Associated Policy or Standard Operating Procedures NICE Implementation Standard Operating Procedure Contents 1. Introduction Definitions Purpose Responsibilities Monitoring Compliance... 5 Change Control Amendment History Version Dates Amendments
2 1. Introduction Good clinical guidance, successfully implemented, can improve the healthcare of the whole population. Successful implementation depends on the effectiveness of the implementation process and its acceptance by all healthcare professionals, service users and carers. The National Institute for Clinical Excellence (NICE) was set up in April 1999 its role is to provide patients, healthcare professionals, and the public with authoritative, robust, reliable guidance on best practice. NICE provides several types of guidance: 2. Definitions i. Clinical guidelines guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS in England and Wales. ii. Public health guidelines - guidance making recommendations for populations and individuals on activities, policies and strategies that can help prevent disease or improve health. The guidance may focus on a particular topic (such as smoking), a particular population (such as schoolchildren) or a particular setting (such as the workplace). iii. Social Care guidelines - guidelines aiming to improve outcomes for people who use social care support by ensuring that social care services and interventions are effective and cost-efficient. iv. NICE guidelines From January 2015 all guidance previously released under the headings of Clinical guidelines (CG), Public health guidance (PH) and Social Care guidelines (SC) are being classified as NICE guidelines (NG) v. Technology appraisals guidance on the use of new and existing medicines and treatments within the NHS in England and Wales vi. Interventional procedures - procedures used for diagnosis or for treatment that involves making a cut or a hole to gain access to the inside of a patient's body, gaining access to a body cavity, using electromagnetic radiation. vii. Medical technologies guidance - focuses specifically on the evaluation of innovative medical technologies (including devices and diagnostics). viii. Diagnostic technologies guidance - focuses on the evaluation of innovative medical diagnostic technologies in order to ensure that the NHS is able to adopt clinically and cost effective technologies more rapidly and consistently. ix. Cancer service guidance - The focus of the cancer service guidance is to guide the commissioning of services and is therefore different from clinical practice guidelines. It is based upon the implementation of the NHS Cancer Plan Page 2 of 5
3 It is the first 6 sets of guidelines which relate to services provided by South Staffordshire and Shropshire NHS Foundation Trust. 3. Purpose This policy aims to describe the Trust s process of responding effectively to NICE guidance, which should result in benefits to patients, ensuring that the care provided is both clinically and cost effective. The process supports the Trust s Quality Framework and provides assurance to the board. The purpose is to ensure that NICE guidance is distributed to all appropriate personnel, that implementation is monitored when required and that suitable records are maintained, as directed by the Clinical Audit Project Group. 4. Responsibilities Trust Board is responsible for: Setting policy for the organisation through powers delegated to relevant committees; Ensuring policy is implemented through agreed management arrangements; Ensuring they are alerted to relevant issues arising that may affect policy; Recognising the importance of a system being in place to ensure the dissemination, implementation and monitoring of NICE guidance. Quality Governance Committee reports to the Board will provide assurance that the Board members are kept informed and that the system is working effectively. Associate Director of Quality and Risk The Director of Quality and Clinical Performance has overall delegated responsibility for the implementation of NICE guidance within the Trust. The Associate Director of Quality and Clinical Performance is ultimately accountable for the process of dissemination, implementing and monitoring of NICE guidance effectively and efficiently, and has determined that this responsibility is delegated to the directors(s) with lead responsibilities for clinical quality and the Clinical Audit Team. Responsibilities also include: Supported by the Clinical Audit Project Group (CAPG) and Clinical Audit Team, initial assessment of relevance to the trust, of newly published NICE guidance and subsequent allocation clinical directors to identify or confirm nominated lead for the production of a position statement and implementation. Supported by the Clinical Audit project Group, review completed position statements and recommendations/implementation plans. Production of regular reports to commissioners detailing progress against NICE guidance implementation. Horizon scanning and forward planning in relation to NICE guidance; Page 3 of 5
4 Clinical Directors are responsible for: Identifying a lead from their directorate for each appropriate NICE Guideline to lead on the development of a position statement and implementation. Ensuring NICE guidance is disseminated and implemented in line with relevant pathways. Relevant clinical audit activity is undertaken to support assurances around the implementation of NICE recommendations. Clinical Audit Team The Clinical Audit Team shall have responsibility for the distribution and monitoring of NICE guidance, within the Trust. Duties include a responsibility to: Disseminate newly published guidance to the Associate Director of Quality and Risk and CAPG to assess relevance to the Trust and identify appropriate clinical director(s) and or implementation leads; Coordinate completion of position statements within a timely manner, using the agreed Trust template; Maintain a database of Trust responses to NICE guidance; Develop a programme of systematic NICE Guidance audits within the Clinical Audit Forward Programme, based upon Trust priorities and supported by recommendations within completed position statements; Produce quarterly progress reports for the Quality Governance Committee; Disseminate and raise awareness of newly published relevant NICE guidance to staff within the trust in conjunction with Trust library services; Where the decision has been made to not implement a piece of NICE guidance, this shall be recorded in the minutes of the Clinical Audit Project Group, recorded on the NICE database and shared within the report to the Quality Governance Committee. Medicines Optimisation Committee Judge relevance of NICE Technology Appraisals to the organisation. Appoint an appropriate individual to develop a position statement for each relevant Technology Appraisal. Agree and monitor NICE audit activity. Identify and agree a time period for delivery of audit report action plans. Ensure re-audit criteria and timeframe are included in the Clinical Audit Forward Plan. Chief Pharmacist The Chief Pharmacist will ensure Technology Appraisals are reviewed by Medicines Optimisation Committee and assess the current status of any prescribing issues within the Trust. Page 4 of 5
5 Directorate Governance Groups are responsible for: Supporting the production of NICE position statements from a nominated clinical lead; Providing opportunities for sharing and discussing the implementation of newly published NICE guidance; Agreeing a programme of clinical audit activity that encompasses all relevant NICE guidance, as well as approving subsequent audit recommendations and monitoring their implementation. Identified Leads are responsible for: Ensuring that an initial position statement/gap analysis review is undertaken for any NICE guidance/quality Standard for which they have been identified as the lead. Formulating a robust action plan to address any areas of partial or non-compliance and sharing these with directorate governance groups the Clinical Audit Project Group. Make recommendations in the position statement action plan as to the frequency of related clinical audit to be included in the Trusts rolling annual audit programme. Monitoring the implementation of position statement recommendations and supporting subsequent clinical audit activity. 5. Monitoring Compliance The Clinical Audit Project Group shall provide a summary report to the Quality Governance Committee on a quarterly basis, showing progress against the implementation and monitoring of relevant NICE guidance. The Clinical Audit Project Group will monitor the content of clinical audit forward programme to ensure all relevant NICE guidance is subject to structured assessment of compliance. Page 5 of 5
Appendix 1. Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance
Appendix 1 Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance Policy Title: Executive Summary: Policy on the dissemination, implementation and monitoring of national
More informationPOLICY ON THE IMPLEMENTATION OF NICE GUID ANCE
POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE Document Type Corporate Policy Unique Identifier CO-019 Document Purpose To outline the process for the implementation and compliance with NICE guidance and
More informationVELINDRE NHS TRUST. Trust Procedure PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE
Clinical Excellence (NICE) Guidance VELINDRE NHS TRUST Trust Procedure Black 21 PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE Lead: Lisa Heydon-Mann
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationNICE Charter Who we are and what we do
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
More informationUse of Long Term Segregation: Standard Operating Procedure
Clinical Use of Long Term Segregation: Standard Operating Procedure Document Control Summary Status: New Version: v1.0 Date: October 2015 Author/Title: Gary Firkins De-escalation Management & Intervention
More informationNHS England (Wessex) Clinical Senate and Strategic Networks. Accountability and Governance Arrangements
NHS England (Wessex) Clinical Senate and Strategic Networks Accountability and Governance Arrangements Version 6.0 Document Location: This document is only valid on the day it was printed. Location/Path
More informationDocument Details Clinical Audit Policy
Title Document Details Clinical Audit Policy Trust Ref No 1538-31104 Main points this document covers This policy details the responsibilities and processes associated with the Clinical Audit process within
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationCorporate. Health and Safety Policy. Document Control Summary. Contents
Corporate Health and Safety Policy Document Control Summary Status: Version: Author/Title: Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide
More informationNICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
NICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes Louise Picton Medicines Advice Senior Adviser, Medicines and Prescribing Centre Outline
More informationMay 2016 March 2019 Mentorship, mentors, sign off mentors
Clinical Mentorship of Student Nurses Policy and Procedure Document Control Summary Status: Version: Author/Title: Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationPutting Barnsley People First. Quality and Patient Safety Committee Terms of Reference
Putting Barnsley People First Quality and Patient Safety Committee Terms of Reference 1. Introduction NHS Barnsley Clinical Commissioning Group Quality and Patient Safety Committee 1.1 The Clinical Commissioning
More informationCleaning of the Environment: Standard Operating Procedure
Facilities and Estates Cleaning of the Environment: Standard Operating Procedure Document Control Summary Status: New Version: v1.0 Date: September 2015 Author/Title: Author/Title: Author/Title: Owner/Title:
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationAbu Dhabi Occupational Safety and Health System Framework (OSHAD-SF) Mechanisms
Abu Dhabi Occupational Safety and Health System Framework (OSHAD-SF) Mechanisms Mechanism 2.0 OSHAD-SF Administration Version 3.1 March 2017 Table of Contents 1. Introduction... 3 2. Roles and Responsibilities...
More informationClinical Supportive Observation, Intervention and Engagement of Service Users Policy
Clinical Supportive Observation, Intervention and Engagement of Service Users Policy Document Control Summary Status: Version: Author/Title: Owner/Title: Approved by: Ratified: Related Trust Strategy and/or
More informationHealth and Safety Policy Part 1 Policy and organisation
Health and Safety Policy Part 1 Policy and organisation ICO H&S Policy Policy and organisation, June 2016 Page 1 of 5 1. Scope 1.1 The Health and Safety policy applies to all employees of the Information
More informationLearning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care.
Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care. Associated Policies Being Open and Duty of Candour policy CG10 Clinical incident / near-miss
More informationPATIENT SAFETY AND QUALITY COMMITTEE TERMS OF REFERENCE
PATIENT SAFETY AND QUALITY COMMITTEE TERMS OF REFERENCE Page 1 DOCUMENT CONTROL SHEET Name of Document: Patient Safety and Quality Committee Terms of Reference Version: 5 File Location / Document Name:
More informationPatient Experience Strategy
Patient Experience Strategy 2013 2018 V1.0 May 2013 Graham Nice Chief Nurse Putting excellent community care at the heart of the NHS Page 1 of 26 CONTENTS INTRODUCTION 3 PURPOSE, BACKGROUND AND NATIONAL
More informationCorporate. Visitors & VIP s Standard Operating Procedure. Document Control Summary. Contents
Corporate Visitors & VIP s Standard Operating Procedure Document Control Summary Status: Version: Author/Owner: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date:
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: Finance, Performance and Commissioning Committee Report 3. Key Messages: At the end of March 2017 the clinical commissioning
More informationClinical Preceptorship Policy: (Registered professionals entering employment at Band 5)
Clinical Clinical Preceptorship Policy: (Registered professionals entering employment at Band 5) Document Control Summary Status: Version: Author/Title: Owner/Tile: Approved by: Ratified: Related Trust
More informationNHS QIS & NICE Advice. defi nitions & status
NHS QIS & NICE Advice defi nitions & status NHS Quality Improvement Scotland 2006 First published August 2006 You can copy or reproduce the information in this document for use within NHSScotland and for
More informationabcdefghijklmnopqrstu
Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy
More informationTESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN ENGLAND NOVEMBER 2016
TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN ENGLAND NOVEMBER 2016 EXECUTIVE SUMMARY Whilst cancer survival is at its highest ever level, our health services are under considerable pressure.
More informationHealth and Safety Policy for Prince of Wales Primary School
London Borough of Enfield Health and Safety Policy Prince of Wales Primary School January 2017 Name Signature Date Prepared by: Checked and Reviewed by: Approved by: Paul Bishop Notified and agreed. Jan
More informationHow to use NICE guidance to commission high-quality services
How to use NICE guidance to commission high-quality services Acknowledgement We are grateful to the many organisations and individuals who have contributed to the development of this guide. A list of these
More informationBest Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationANTI-COAGULATION MONITORING
ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This
More informationIssue date: October Guide to the multiple technology appraisal process
Issue date: October 2009 Guide to the multiple technology appraisal process Guide to the multiple technology appraisal process Issued: October 2009 This document is one of a series describing the processes
More informationBritish Association of Dermatologists
Guidance producer: British Association of Dermatologists Guidance product: Service Guidance and Standards Date: 13 March 2017 Version: 1.2 Final Accreditation Report Page 1 of 26 Contents Introduction...
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationAppendix 1 MORTALITY GOVERNANCE POLICY
Appendix 1 MORTALITY GOVERNANCE POLICY 1 Policy Title: Executive Summary: Mortality Governance Policy For many people death under the care of the NHS is an inevitable outcome and they experience excellent
More informationRESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO ACCESS TO MEDICAL TECHNOLOGIES IN WALES
Recommendations 1, 2, 3 1. That the Minister for Health and Social Services should, as a matter of priority, identify means by which a more strategic, coordinated and streamlined approach to medical technology
More informationMedicines Optimisation Strategy
Medicines Optimisation Strategy 2014-2017 Contents Section Page 1 Foreword 3 2 Strategic Principles for Medicines Optimisation 4 3 Introduction 4 4 Trust Vision and Values 5 5 Strategy Development 5 6
More informationNICE s Highly Specialised Technologies (HST) evaluation committee
NICE s Highly Specialised Technologies (HST) evaluation committee Graham Foxon EUCOPE P&R / Market Access Working Group Meeting 20 th November 2014 Remap Consulting is a specialist pricing and market access
More informationASBESTOS MANAGEMENT POLICY
ASBESTOS MANAGEMENT POLICY Version 5.0 File ref ASBESTOS MANAGEMENT POLICY Date approved June 2016 Date to be reviewed June 2019 To by reviewed by ASBESTOS STEERING GROUP Asbestos Management Policy June
More informationNorthern Ireland Peer Review of Cancer MDTs. EVIDENCE GUIDE FOR LUNG MDTs
Northern Ireland Peer Review of Cancer MDTs EVIDENCE GUIDE FOR LUNG MDTs CONTENTS PAGE A. Introduction... 3 B. Key questions for an MDT... 6 C. The Review of Clinical Aspects of the Service... 8 D. The
More informationNorth of Scotland Quality and Governance Framework for Cancer
North of Scotland Quality and Governance Framework for Cancer Aim There has been two significant guidance and direction given by the Scottish Government Health Department in respect to the delivery and
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationMoving and Handling Policy
Moving and Handling Policy Ratified Quality, Patient Safety and Risk / 16/04/2014 / 2014-40 Status Ratified Issued April 2014 Approved By Quality, Patient Safety and Risk Committee Consultation Quality,
More informationNHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence
NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development
More informationNorth Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8
North Central London Medicines Optimisation Network Medicines Optimisation Committee Terms of Reference North Central London Medicines Optimisation Network 1 of 8 Document control Date Version Amendments
More informationImplementation of the right to access services within maximum waiting times
Implementation of the right to access services within maximum waiting times Guidance for strategic health authorities, primary care trusts and providers DH INFORMATION READER BOX Policy HR / Workforce
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Quality Committee (known as the Committee in these terms of reference) for the purpose of:
More informationStandards of Proficiency for Higher Specialist Scientists
Standards of Proficiency for Higher Specialist Scientists July 2015 Version 1.0 Review date: 31 July 2016 Contents Introduction... 3 About the Academy Register - Practitioner part... 3 Routes to registration...
More informationCentral Alerting System (CAS) Policy
Central Alerting System (CAS) Policy Reference No: P_CIG_03 Version 3 Ratified by: LCHS Trust Board Date ratified: 12 th July 2016 Name of responsible committee / Individual Date issued: July 2016 Review
More informationSpecialised Commissioning Oversight Group. Terms of Reference
Specialised Commissioning Oversight Group Terms of Reference Specialised commissioning oversight group terms of reference 1 1.1 Purpose NHS England is responsible for commissioning specialised services
More informationEnhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people
Enhanced service specification Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 1 Enhanced service specification Avoiding unplanned admissions: proactive case
More informationInitial education and training of pharmacy technicians: draft evidence framework
Initial education and training of pharmacy technicians: draft evidence framework October 2017 About this document This document should be read alongside the standards for the initial education and training
More informationCLINICAL GOVERNANCE STRATEGY. For West Sussex PCT
CLINICAL GOVERNANCE STRATEGY For West Sussex PCT 2006 2009 Agreed by the Clinical Governance Committee: 31/01/07 Effective from: 31/01/07 Review: 31/07/07 Page 1 of 8 Contents Page Introduction 3 Principles
More informationHospital Discharge and Transfer Guidance. Choice, Responsiveness, Integration & Shared Care
Hospital Discharge and Transfer Guidance Choice, Responsiveness, Integration & Shared Care Worcestershire Mental Health Partnership NHS Trust Information Reader Box Document Type: Document Purpose: Unique
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationModernising Learning Disabilities Nursing Review Strengthening the Commitment. Northern Ireland Action Plan
Modernising Learning Disabilities Nursing Review Strengthening the Commitment Northern Ireland Action Plan March 2014 INDEX Page A MESSAGE FROM THE MINISTER 2 FOREWORD FROM CHIEF NURSING OFFICER 3 INTRODUCTION
More informationNational Framework for NHS Continuing Healthcare and NHS-funded Nursing Care in England. Core Values and Principles
National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care in England Core Values and Principles Contents Page No Paragraph No Introduction 2 1 National Policy on Assessment 2 4 The Assessment
More informationNon-Medical Prescribing Strategy
Non-Medical Prescribing Strategy 2014-2017 Nursing & Partnerships Directorate Page 1 of 13 Section Contents Page No. 1. STATEMENT OF INTENT 3 2. PURPOSE 3 3. SCOPE 3 4. BACKGROUND 3 5. STRATEGIC GOALS
More informationNational Cervical Screening Programme Policies and Standards. Section 2: Providing National Cervical Screening Programme Register Services
National Cervical Screening Programme Policies and Standards Section 2: Providing National Cervical Screening Programme Register Services Citation: Ministry of Health. 2014. National Cervical Screening
More informationNorth School of Pharmacy and Medicines Optimisation Strategic Plan
North School of Pharmacy and Medicines Optimisation Strategic Plan 2018-2021 Published 9 February 2018 Professor Christopher Cutts Pharmacy Dean christopher.cutts@hee.nhs.uk HEE North School of Pharmacy
More informationLEARNING FROM DEATHS (Mortality Policy)
LEARNING FROM DEATHS () Version: 1.0 Date issued: October 2017 Review date: September 2020 Applies to: All Clinical Staff Groups This document is available in other formats, including easy read summary
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationQuality Assurance Framework
Quality Assurance Framework NHS Bromley Clinical Commissioning Group Quality Assurance Framework was developed to support the commissioning, contract monitoring and procurement processes. NAME OF ORGANISATION/SERVICE
More informationClinical. Prescribing Medicines SOP. Document Control Summary. Contents
Clinical Prescribing Medicines SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key
More informationReady for revalidation. Supporting information for appraisal and revalidation
2012 Ready for revalidation Supporting information for appraisal and revalidation During their annual appraisals, doctors will use supporting information to demonstrate that they are continuing to meet
More informationMedicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
More informationReplacement. Supersedes: Complaints Procedure ( ) and the Patient Advice and Liaison Service Policy ( )
Corporate Complaints: Standard Operating Procedure Document Control Summary Status: Replacement. Supersedes: Complaints Procedure (28.10.10) and the Patient Advice and Liaison Service Policy (28.07.11)
More informationMethods: Commissioning through Evaluation
Methods: Commissioning through Evaluation NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy
More informationVersion: 3.0. Effective from: 29/08/2012
Policy No: RM51 Version: 3.0 Name of policy: Learning from Experience Policy A systematic approach to incident, complaint and clai management, analysis and sharing safety lessons Effective from: 29/08/2012
More informationPolicy on the Commissioning of NHS Continuing Healthcare for Adults: Assuring Equity, Choice and Value for Money
Policy Statement No. Salford Clinical Commissioning Group Policy on the Commissioning of NHS Continuing Healthcare for Adults: Assuring Equity, Choice and Value for Money Lead for development & revisions
More informationAcutely ill patients in hospital
Issue date: July 2007 Acutely ill patients in hospital Recognition of and response to acute illness in adults in hospital Developed by the Centre for Clinical Practice at NICE Contents Key priorities for
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationSupporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013
Supporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as
More informationNew v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee
Clinical Pharmacy Services: SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words:
More informationREVIEW AND UPDATE OF THE COMMITTEE WORK PROGRAMME
AGENDA ITEM 3.1 14 June 2013 REVIEW AND UPDATE OF THE COMMITTEE WORK PROGRAMME Executive Lead: Committee Chair Author: Assistant Director of Patient Safety & Quality Contact Details for further information:
More informationPathology Quality Review : Outcomes and Update
Pathology Quality Review : Outcomes and Update Dr Ian Barnes UK NEQAS (H) 17 th Annual Meeting National Motorcycle Museum Tuesday 14 th October, 2014 The Review Launched January 28 th, 2014. (england.pathqareview@nhs.net)
More informationAnnounced Care Inspection Report 9 October N Wright Dental Practice Ltd
Announced Care Inspection Report 9 October 2017 N Wright Dental Practice Ltd Type of Service: Independent Hospital (IH) Dental Treatment Address: 115 Holywood Road, Belfast, BT4 3BE Tel No: 028 9047 1471
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting 16 th November 2017 2. Title of Report: 3. Key Messages: BUPA ceased to be the registered provider of Crawfords Walk Nursing Home in October. The
More informationQuality Governance (Audit, Compliance and CQC) Manager
Quality Governance (Audit, Compliance and CQC) Manager Service Location Central Office Worcester Cranstoun is a charity empowering people to live healthy, safe and happy lives. Our skilled and compassionate
More informationInternal Audit. Health and Safety Governance. November Report Assessment
November 2015 Report Assessment G G G A G This report has been prepared solely for internal use as part of NHS Lothian s internal audit service. No part of this report should be made available, quoted
More informationAwarding body monitoring report for: The Graded Qualifications Alliance (GQAL) August Ofqual/09/4634
Awarding body monitoring report for: The Graded Qualifications Alliance (GQAL) August 2009 Ofqual/09/4634 2009 Office of the Qualifications and Examinations Regulator 2 Contents Introduction...4 Regulating
More informationClinical Advisory Forum DRAFT Terms of Reference
Clinical Advisory Forum DRAFT Terms of Reference 1. Constitution 1.1. The Trust Executive Committee (TEC) hereby resolves to establish a Forum to be known as the Clinical Advisory Forum (the Forum). The
More informationMoving and Handling Policy
Moving and Handling Policy Ratified Status Approved Final Issued 28 April 2016 Approved By Quality, Patient Safety and Risk Committee Consultation Executive Committee Equality Impact Assessment Embedded
More informationQuality Framework Healthier, Happier, Longer
Quality Framework 2015-2016 Healthier, Happier, Longer Telford & Wrekin Clinical Commissioning Group (CCG) makes quality everyone s business. Our working processes are designed to ensure we all have the
More informationNorthumberland, Tyne and Wear NHS Foundation Trust. Board of Directors Meeting. Meeting Date: 25 October Executive Lead: Rajesh Nadkarni
Agenda item 9 ii) Northumberland, Tyne and Wear NHS Foundation Trust Board of Directors Meeting Meeting Date: 25 October 2017 Title and Author of Paper: Clinical Effectiveness (CE) Strategy update Simon
More informationMortality Policy. Learning from Deaths
Mortality Policy Learning from Deaths Name of Author and Job Title: Frank Jacobs, Datix project manager Ian Brandon, Head of governance and risk Name of Review/ Development Body: Ratification Body: Mortality
More informationCare Programme Approach Policies and Procedures. Choice, Responsiveness, Integration & Shared Care
Care Programme Approach Policies and Procedures Choice, Responsiveness, Integration & Shared Care Worcestershire Mental Health Partnership NHS Trust Information Reader Box Document Type: Document Purpose:
More informationFacilities and Estates. Safety and Suitability of Premises Policy. Document Control Summary. Contents. New. Status:
Facilities and Estates Safety and Suitability of Premises Policy Document Control Summary Status: New Version: v1.0 Date: 29/1/2016 Author/Title: Owner/Title: Simon Davidson Assistant Director of Facilities
More informationAnti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
More informationFinal Accreditation Report
Guidance producer: Royal College of Surgeons of England: Surgical Specialty Associations Guidance product: Clinical Commissioning Guides Date: 28 February 2013 Version: 1.3 Final Accreditation Report Royal
More informationSupporting information for appraisal and revalidation: guidance for psychiatry
Supporting information for appraisal and revalidation: guidance for psychiatry Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose of revalidation
More information2. DEVELOPING AND DELIVERING A SINGLE GOVERNANCE STRUCTURE
GOVERNANCE COMMITTEE SEPTEMBER 2018 SINGLE GOVERNANCE COMMITTEE PROPOSAL 1. INTRODUCTION As both Trusts continue to work more closely together and work is in progress to achieve a formal merger it is necessary
More information